BeOne Medicines (ONC) FCF Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 723.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -1,409.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 6,066.00 |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 15,064.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,064.00 |
| Dec 31, 2025 | 13,457.00 |
| Sep 30, 2025 | 20,191.00 |
| Jun 30, 2025 | 14,616.00 |
| Mar 31, 2025 | 9,044.00 |
| Dec 31, 2024 | -6,777.00 |
| Sep 30, 2024 | 27,806.00 |
| Jun 30, 2024 | 29,142.00 |
| Mar 31, 2024 | -6,051.00 |
| Dec 31, 2023 | 31,195.00 |
| Sep 30, 2023 | 39,015.00 |
| Jun 30, 2023 | 33,181.00 |
| Mar 31, 2023 | 55,801.00 |
| Dec 31, 2022 | 46,008.00 |
| Sep 30, 2022 | 34,224.00 |
| Jun 30, 2022 | -8,583.00 |
| Mar 31, 2022 | 15,713.00 |
| Dec 31, 2021 | 39,168.00 |
| Sep 30, 2021 | 4,327.00 |
| Jun 30, 2021 | -9,490.00 |
| Mar 31, 2021 | 36,645.00 |
| Dec 31, 2020 | -107,314.00 |
| Sep 30, 2020 | -37,688.00 |
| Jun 30, 2019 | 624,765.00 |
| Mar 31, 2019 | 316,961.00 |
| Dec 31, 2018 | 3,043.00 |
| Sep 30, 2018 | 53,449.00 |
| Jun 30, 2018 | 23,753.00 |
| Mar 31, 2018 | 15,258.00 |